The owner said they cannot let the cat in the room at night because they would not be able to monitor him with the rabbit.
International team uncovers gene mutations that cause rare and aggressive cancer in both cats and humans. Their findings could provide a path to treatments for both species.Cat lovers have more in ...
The first study of multiple cancer types in cats has identified genetic changes that could help treat the condition in humans and animals. By analyzing different types of tumors from almost 500 pet ...
A microbe involved in gum disease could fan the flames of breast cancer. In mice, the oral bacterium can swell the size of existing tumors and even spark the formation of precancerous growths, ...
Add Yahoo as a preferred source to see more of our stories on Google. Image Via: Nara_money/Shutterstock (Image Via: Nara_money/Shutterstock) There are two types of ...
HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/ -- VolitionRx Limited (VNRX) ("Volition"), a multi-national epigenetics company, announces results from a clinical study demonstrating the high accuracy of ...
HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/--VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces results from a ...
Oral bacteria and fungi may help reshape the pancreatic microbiome and promote carcinogenesis. Earlier research has connected periodontal disease and clinical candidiasis with greater pancreatic ...
New research suggests that even light alcohol use may carry serious risks. A large study in India found that drinking just one standard drink a day is linked to a roughly 50% higher risk of mouth ...
Even a low daily intake of alcohol--just 9 g or around one standard drink-is linked to a 50% heightened risk of mouth (buccal mucosa) cancer in India, with the greatest risk associated with locally ...
Even a low daily intake of alcohol—-just 9 g or around one standard drink—is linked to a 50% heightened risk of mouth (buccal mucosa) cancer in India, with the greatest risk associated with locally ...
Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader (SERD) to a 30% reduction in the risk of invasive disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results